No company can match StemCyte's LifeSaver Guarantee!
With StemCyte's Hybrid model you will naturally
receive support and options at NO additional cost
If for any reason your newborn's cord blood unit fails to engraft, StemCyte's LifeSaver Guarantee will:
-
Find a replacement at no cost to parents from StemCyte's public inventory.
-
Refund All Fees.
-
Provide parents with an additional $50k.
Cord Blood & Tissue Banking
Cord Blood & Tissue Banking
Cord Blood & Tissue Banking
MaxCell®
Annual Cord Blood Plans
FDA Approved Treatments
Cord Blood Stem Cells
FDA Approved Treatments
Cord Blood Stem Cells
Cord Blood Cord blood contains a rich source of various cells including hematopoietic stem cells which form blood cells. Today, there are 80 diseases that can be treated with cord blood stem cells. Also, there are more than 100 active cord blood stem cell clinical trials worldwide investigating the treatment of various diseases like autism.
An Overview
StemCyte's Top Advantages
There are many important things to consider before choosing a company to preserve your newborn's cord blood and cord tissue. As pioneers in regenerative medicine, StemCyte knows what truly matters at every step of banking. We hope this list of our top advantages will give you the confidence in our science, products, and the people who will care for your family's future health and well-being.
An Overview
StemCyte's Top Advantages
There are many important things to consider before choosing a company to preserve your newborn's cord blood and cord tissue. As pioneers in regenerative medicine, StemCyte knows what truly matters at every step of banking. We hope this list of our top advantages will give you the confidence in our science, products, and the people who will care for your family's future health and well-being.
Cord Blood & Cord Tissue Preservation
(866) 389-4659
The Potential of Cord Tissue Stem Cells
Treating COVID-19
Since the start of the global COVID-19 pandemic, academic research centers and scientists from around the world have been testing the potential of newborn cord tissue stem cells to combat this virus. In addition to the cord tissue stem cell clinical trials for COVID-19, there are numerous active clinical trials using cord tissue stem cells to treat heart disease, diabetes, Alzheimer’s disease, and many other serious health conditions.
Why are cord tissue stem cells being used in clinical trials as a possible treatment for COVID-19?
Cord tissue contains mesenchymal stem cells (MSCs). These cells are important for several reasons. First, they have the ability to differentiate into a variety of cell types within the body. Second, MSCs contain and secrete powerful cytokine proteins that can repair and regulate a variety of functions such as inflammation. Medical professionals hypothesize that reducing and regulating inflammation is critical in treating COVID-19 patients. For the aforementioned reasons, MSCs continue to be tested as a potential treatment of COVID-19 as well as other life-threatening health conditions.
StemCyte’s Ongoing Support of Families
As a pioneer in regenerative medicine, you can be assured that StemCyte remains active and abreast of key information that can help, educate, and support expectant parents and families. Today, StemCyte maintains strong partnerships with some of the top medical facilities and hospitals in the United States and 350+ cord blood transplant centers worldwide.
Why Consider Cord Blood & Tissue Preservation?
The COVID-19 pandemic has been a major wake-up-call in being prepared emotionally, financially, and physically in the event of a health crisis. The toll that this pandemic has taken on families is not easily measured. StemCyte’s mission to help families face and fight life threatening health conditions and diseases has never been more important! Because cord blood stem cells are used daily and approved for treatment by the FDA in 80+ health conditions and diseases, we encourage parents to preserve their newborn’s cord blood and tissue for their peace-of-mind and the future health of their family.
Reference: 1. Jiancheng Zhang, Bing Xie and Kenji Hashimoto, Bran, Behavior, and Immunity, https://www.sciencedirect.com/science/article/pii/S0889159120305894
2. Pain Physician 2020; 23:E71-E83 • ISSN 2150-1149 https://www.painphysicianjournal.com/current/pdf?article=NzAyNA%3D%3D